Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2070 W Rudasill Rd
Ste 130
Tucson, AZ 85704Phone+1 520-797-4468Fax+1 520-797-4502
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1983 - 1986
University of Florida College of MedicineClass of 1983
National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
NY State Medical License 1986 - Present
AZ State Medical License 1990 - 2026
FL State Medical License 1987 - 1998
MD State Medical License 1987 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
- Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Publications & Presentations
PubMed
- 50 citationsPhase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancerGiorgio V. Scagliotti, Jin Hyoung Kang, David J. Smith, Richard K. Rosenberg, Keunchil Park
Investigational New Drugs. 2016-06-27 - 8 citationsFavorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck ca...Dennis L. Carter, Lina Asmar, David Barrera, John Caracandas, J. Shaker Dakhil
Investigational New Drugs. 2008-05-13 - 24 citationsProtein kinase Cβ expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetateMarianne B. Powell, Richard K. Rosenberg, Mark J. Graham, Mary Birch, Douglas T. Yamanishi
Journal of Cancer Research and Clinical Oncology. 1993-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
